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Abstract
Background: Pyogenic tonsillitis may often be observed in the general Western population. In severe cases, it may
require antibiotic treatment or even hospitalization and often a prompt clinical response will be noted. Here we
present an unusual case of progressive multiple organ failure including fulminant liver failure following acute
tonsillitis initially mistaken for “classic” pyogenic (that is bacterial) tonsillitis.
Case presentation: A 68-year-old previously healthy white man was referred with suspicion of pyogenic angina.
After tonsillectomy, he developed acute liver failure and consecutive multiple organ failure including acute
hemodynamic, pulmonary and dialysis-dependent renal failure. Immunohistopathological analysis of his tonsils and
liver as well as serum polymerase chain reaction analyses revealed herpes simplex virus-2 to be the causative
pathogen. Treatment included high-dose acyclovir and multiorgan supportive intensive care therapy. His final
outcome was favorable.
Conclusions: Fulminant herpes simplex virus-2-induced multiple organ failure is rarely observed in the Western
hemisphere and should be considered a potential diagnosis in patients with tonsillitis and multiple organ failure
including acute liver failure. From a clinical perspective, it seems important to note that fulminant herpes simplex
virus-2 infection may masquerade as “routine” bacterial severe sepsis/septic shock. This persevering condition
should be diagnosed early and treated goal-oriented in order to gain control of this life-threatening condition.
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Background
In the general Western population, pyogenic (that is
bacterial) tonsillitis may often be observed and it is
known to account for a large number of pre-clinical
consultations. In severe cases, it may require antibiotic
treatment or even hospitalization and a prompt clinical
response will often be noted [1–3]. Here we present
an unusual case of progressive multiple organ failure
including fulminant liver failure following acute non-
bacterial tonsillitis. We will furthermore report and
discuss pitfalls in the clinical management of such
life-threatening non-bacterial tonsillitis.
Case presentation
A 68-year-old white man with an insignificant past
medical history (including sexual history) was referred
to our tertiary care academic center with symptoms of
acute tonsillitis, clinically not responding to antibiotic
treatment with oral amoxicillin-clavulanic acid. Fol-
lowing a 2-day course of moderate fever (38 °C) and
sore throat with highly elevated infection parameters
of C-reactive protein 280 mg/l, white blood cell count
(WBC) 4.8 G/L, and platelets 106 G/L, he was hospi-
talized for intravenous antibiotic treatement. An initial
physical examination at admission was unremarkable.
Due to a progressive elevation in his inflammatory
markers along with clinical deterioration and progres-
sive tonsillar inflammation, a left-sided tonsillectomy
was performed 48 hours after his hospital admission.
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During his postoperative course, fulminant acute liver
failure (ALF) was observed and he was transferred to
our intensive care unit (ICU) for further investigations
and supportive intensive care treatment.
At ICU admission, laboratory analyses revealed
leukopenia (1.8 G/l) with pan-lymphopenia and marked
elevation of indices of liver dysfunction (Table 1). Toxic,
vascular/ischemic, autoimmune, or metabolic liver disease
was considered unlikely following anamnesis and respective
laboratory tests (please also refer to Table 1). In addition to
laboratory signs of ALF, the patient soon developed acute
kidney injury/failure: risk, injury, failure, loss of kidney
function, and end-stage kidney disease (RIFLE) category
“F”. An emergency abdominal ultrasound revealed moder-
ate hepatic steatosis, and computed tomography imaging
revealed inhomogeneous hepatic steatosis, ascites and
moderate splenomegaly. A retropharyngeal abscess was
ruled out. Infective tonsillitis-induced septic shock with
progressive multiple organ failure was suspected and the
initial antibiotic treatment using amoxicillin-clavulanic
acid was changed to ciprofloxacin, Cubicin (daptomycin)
and metronidazole. During the further course of the
disease, supportive medical treatment included high-dose
acetylcysteine, vitamin K and lactulose. However, further
worsening of liver function tests was noted and a decision
for a transjugular liver biopsy was established 48 hours
following his ICU admission. Initial histologic findings
revealed diffuse hepatic necrosis compatible with viral
hepatitis (Fig. 1); empirical antiviral treatment using ganci-
clovir (500 mg single-shot, followed by 450 mg twice a
day) was commenced in order to cover cytomegalovirus
(CMV) and herpes simplex virus (HSV). In addition,
initial results showed seropositivity for HSV-2 immuno-
globulin G (IgG), Epstein–Barr virus (EBV) IgG and CMV
IgG. Serological testing for human immunodeficiency
virus (HIV) and for hepatitis B and hepatitis C revealed
negative results. Final histological results of his liver then
demonstrated significant HSV-1 and HSV-2 immunoposi-
tivity. In combination with strongly elevated HSV-2 serum
polymerase chain reaction (PCR) levels (106 to 107 HSV-2
copies/ml) a formal diagnosis of HSV-2-positive hepatitis
was established and treatment with ganciclovir was chan-
ged to acyclovir. The antibiotic therapy was stopped at
this point in time. Due to strong HSV-positivity of hepatic
tissue, tonsillar histologies were re-evaluated for HSV and
marked respective immunopositivity was noted (Fig. 1).
Thus, clinical and histological data strongly suggested
primary HSV-2 tonsillitis.
Along with the development of fulminant ALF, the
major clinical concern was progressive multiple organ
failure. Despite initial “rescue”-steroid dosing, high doses
of norepinephrine (peak dose of 0.3 μg/kg/minute) were
required and progressive capillary leak was observed.
Following a consecutive 48-hour trial of noninvasive
ventilation, the patient required invasive mechanical
ventilation as a consequence of progressive muscular ex-
haustion. He subsequently developed anuric acute renal
failure and renal replacement therapy with intermittent
hemodialysis was initiated. Due to deranged coagulation
in which his platelet count was 56 G/l, prothrombin
time was 38 %, and international normalized ratio (INR)
was 1.82, with recurrent bleeding at the tonsillectomy
site and progressive disseminated intravascular coagu-
lation, an operative revision with ligation of tonsillar
arteries was deemed necessary. High urgency liver
transplantation was discussed as a therapeutic option
but was refrained from due to persisting uncontrolled
infection/multiple organ failure with an expected bad-
verse outcome.
During his course at the ICU, repeated drainage of
ascites was necessary. Aspartate aminotransferase (ASAT)
and alanine aminotransferase (ALAT) serum levels peaked
at day 3 (ASAT 6126U/l, ALAT 3377U/l), and elevated
serum ammonia (123 μmol/l), alkaline phosphatase levels
(520 U/l), and total bilirubin levels were noted (Fig. 2). His
serum factor V levels were 24 % at their lowest (following
prior infusion of fresh frozen plasma). Continuous
norepinephrine application was required for the ensuing 7
weeks due to severe vasoplegic shock and capillary leak.
Table 1 Paraclinical presentation at intensive care unit admission.
Reference ranges are indicated
C-reactive protein <5 mg/L 393
Creatinine 59–104 μmol/L 158
Aspartate aminotransferase <50 U/L 3829
Alanine aminotransferase <50 U/L 2310
Gamma-glutamyltransferase <60 U/L 148
Ammonia 15–55 μmol/L 94
Bilirubin, total <17 μmol/L 101
Bilirubin direct <5 μmol/L 97
Glucose 4.56–6.38 mmol/L 8.4
Prothrombin time 70–130 % 64
Factor V 78–153 % 45
Hemoglobin 135–168 g/L 134
Thrombocytes 140–380 G/L 53
Leukocytes 3.5–10.5 G/L 1.8
Neutrophils 1.60–7.40 G/L 1.66
Eosinophils 0.02–0.40 G/L 0.01
Basophils 0.00–0.15 G/L 0
Monocytes 0.20–0.93 G/L 0.02
Lymphocytes 1.10–3.50 G/L 0.09
Neutrophil bands 3–18 % 63.5
Segmented neutrophils 35–67 % 29
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Extensive sepsis-induced generalized edema was noted
and cardiogenic failure was ruled out by repeated echocar-
diography. As weaning from mechanical ventilation was
complicated by capillary leakage and consecutive volume
overload, a dilative tracheostomy was performed at day
12. In the ensuing days, anuria persisted and continuous
veno-venous hemodiafiltration was performed. Repeated
cultures of urine, blood, sputum and stool specimens all
revealed insignificant microbiological results.
Over the ensuing days, a repeated generalized rash
with herpetic vesicles under continued high-dose acyclo-
vir treatment (initial dose of 2700 mg/day followed by
1500 mg/day for approximately 30 days with respective
adjustment to renal function) was noted (Fig. 3). In the
light of a persevering course of HSV-2-induced multiple
organ failure and continued high titers of “viral load”
(that is 105 to 106 copies of HSV-2 per ml at days 14
and 21), geno-typization of the HSV-2 virus for acyclovir
resistance was performed which revealed negative results.
The patients’ condition finally stabilized after 33 days of
treatment. However, due to persisting lymphopenia and in
view of the overall clinical severity, a prophylactic treatment
with acyclovir (400 mg defined daily dose) was continued.
After approximately 1 month of intensive care treatment,
an overall stabilization of his condition was noted. Norepin-
ephrine was tapered and weaning from the ventilator was
Fig. 1 Hepatic (a-c) and tonsillar (d-e) histology. Liver biopsy tissue shows patchy necrosis comprising 20 to 30 % of the submitted tissue
(a hematoxylin and eosin ×100), with nuclear viral inclusions (b hematoxylin and eosin ×400), immunohistochemically positive for herpes
simplex virus-2 antigen (c ×400). Tonsillar tissue examination discloses acute ulcerating tonsillitis (d hematoxylin and eosin ×100) with
patchy positivity for herpes simplex virus-2 antigen in some remnants of surface epithelium adjacent to the ulcer and in necrotic tissue
overlying the ulcer (e ×200). Photomicrographs were taken on a Zeiss Axiophot2 microscope
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advanced. A diagnosis of ICU-acquired weakness was
established and rehabilitative measures were initiated.
Discussion
In the light of the available literature, HSV-2-induced
multiple organ failure is a rare condition. HSV infection in
adults is commonly associated with cutaneous facial
(HSV-1) or urogenital infections (HSV-2) [4]. Of interest,
approximately 60 % of the Western population is HSV-1
colonized, whereas HSV-2 colonization occurs in approxi-
mately 12 % of cases [4]. Oral HSV infection in adults
may present as severe pharyngitis accounting for approxi-
mately 6 % of cases in young adults. However, HSV-2
seems even scarcer and accounts for approximately <0.5
% of cases [5]. Systemic HSV infection with visceral viral
dissemination may often present as ALF due to fulminant
hepatic necrosis but represents less than 1 % of cases of
ALF [6]. Due to a lack of specific therapeutic options,
HSV hepatitis is associated with mortality rates of up to
90 % [7]. High-risk populations for a fatal course are
immunosuppressed patients and pregnant patients (third
trimester). Of interest, immunocompetency was deemed
in approximately 24 % of severely affected patients [7]. In
our patient, testing for chronic viral disease including HIV
testing, standard examinations including WBCs (following
recovery from lymphopenia), immunoglobulins, distribu-
tion of immune cell subpopulations, and assessment of
major histocompatibility complex (MHC) class II expres-
sion human leukocyte antigen- DR (HLA-DR) [8, 9] did
not reveal a major immunocompromising condition.
Nevertheless, in a case such as in our patient, a potential
underlying immune deficiency should be ruled out.
Because of an unspecific clinical presentation, a diagnosis
of HSV-induced hepatitis may frequently be missed and
data demonstrate that the majority (that is 58 %) of patients
are diagnosed post-mortem [7]. Improved survival rates are
reported following early initiation of antiviral treatment.
Retrospective analyses of patients with HSV hepatitis dem-
onstrate significantly lower mortality rates following early
acyclovir treatment when compared to controls (51 % ver-
sus 88 %). Treatment delay is associated with higher need
for liver transplantation and higher mortality rates [7].
Thus, early initiation of antiviral therapy may be regarded
mandatory to prevent fatal outcomes. Orthotopic liver
transplantation (OLT) in the context of disseminated HSV
infection should be evaluated carefully, as the risk for HSV
recurrence seems increased and lifelong treatment with
acyclovir may be needed following OLT [10]. Although
there is a lack of conclusive data, intensivists should con-
sider treating this life-threatening condition with antiviral
medication over a sustained period of time until profound
clinical improvement is observed. However, optimal dosage,
especially in the presence of acute renal failure, and optimal
timing of treatment for HSV-2-induced multiple organ fail-
ure remains elusive. In addition, it should be kept in mind
that serum PCR levels (that is, respective assessment of
viral load) may reveal positive results for a sustained period
in time. This may be due to amplification of non-live viral
particles and may be misleading in this clinical scenario.
Conclusions
In conclusion, this case demonstrates that HSV-2-induced
multiple organ failure may develop in immunocompetent
hosts following HSV-2 infectious tonsillitis. The clinical
picture may masquerade as “routine” bacterial septic shock
induced by bacterial tonsillitis and may lead to fatal clinical
decisions if not recognized early and treated accordingly.
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Fig. 2 Course of key laboratory parameters used to assess cellular
damage and hepatic dysfunction in patient with multiple organ
failure. Laboratory indices at respective days following intensive care
unit admission. ALAT alanine aminotransferase, alk. alkaline, ASAT
aspartate aminotransferase, GGT gamma-glutamyltransferase
Fig. 3 Eruptions demonstrating generalized herpetic rash at day 8
following intensive care unit admission (left thigh)
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